Pharmacytimes: Condition Center: Acute Coronary Syndrome Acute Coronary Syndrome en-us Mon, 22 Dec 2014 02:47:12 EST Mon, 22 Dec 2014 02:47:12 EST Women with Celiac Disease Shouldn’t Fret Over Fertility Women with celiac disease do not report more fertility problems than the general population. Tue, 09 Dec 2014 09:00:37 EST Reducing Acute Coronary Syndrome Readmission Rates Joe Moose, PharmD, of Moose Pharmacy, discusses the role of the pharmacist in prevention and reducing readmissions among acute coronary syndrome patients. Sat, 06 Dec 2014 01:00:57 EST Acute Coronary Syndrome in Women: A 10-Year Review As pharmacists’ ability to tease out more comprehensive information from clinical trials has increased, it has become evident that social and biologic factors interact to produce paradoxical health differences between men and women, especially on cardiovascular outcomes. Sat, 06 Dec 2014 09:02:01 EST Readmission Rates for Acute Coronary Syndrome Joe Moose, PharmD, of Moose Pharmacy, discusses rising readmission rates among patients with acute coronary syndrome. Fri, 05 Dec 2014 12:57:48 EST Barriers in Acute Coronary Syndrome Drug Adherence Joe Moose, PharmD, of Moose Pharmacy, discusses the unique challenges to adherence that acute coronary syndrome patients face. Thu, 04 Dec 2014 12:56:21 EST Care Transitions for Acute Coronary Syndrome Patients Joe Moose, PharmD, of Moose Pharmacy, discusses the role of the pharmacist in care transitions for acute coronary syndrome patients. Wed, 03 Dec 2014 12:55:01 EST Caring for Acute Coronary Syndrome Patients Joe Moose, PharmD, of Moose Pharmacy, discusses how pharmacists can care for patients with acute coronary syndrome. Tue, 02 Dec 2014 12:51:27 EST Can Polypills Better Prevent Cardiovascular Disease? The pros and cons of fixed-dose combination therapy first became major media news in 2001 when a World Health Organization expert panel proposed polypill use for noncommunicable diseases. Fri, 28 Nov 2014 10:01:01 EST Predicting Poor Outcomes in Myocardial Infarction Researchers identify a potential marker for poor prognosis after acute myocardial infarction. Thu, 06 Nov 2014 12:03:01 EST Selecting Antiplatelet Agents for Diabetics With Acute Coronary Syndrome Many cardiologists and pharmacists are concerned about clopidogrel, especially when it is prescribed for patients with diabetes. Fri, 17 Oct 2014 09:16:43 EDT Starting Statins Soon After Acute Coronary Syndrome Leads to Less Unstable Angina Patients who receive statins soon after acute coronary syndrome are 24% less likely to experience unstable angina after 4 months. Thu, 11 Sep 2014 08:14:01 EDT Statins After ACS: Continue Therapy for at Least 5 Years Patients continue to benefit from high-dose atorvastatin therapy for at least 5 years after acute coronary syndrome, according to a new study. Tue, 19 Aug 2014 04:15:49 EDT Acute Coronary Syndrome: The Sad Facts in Black and White Study finds that black patients who visit the emergency department with ACS have more symptoms and higher symptom severity than white patients. Thu, 24 Jul 2014 09:03:45 EDT Prasugrel or Clopidogrel in ACS: A Head-to-Head Study A recent study examines the comparative efficacy of prasugrel and clopidogrel in the treatment of patients who underwent percutaneous coronary intervention. Mon, 30 Jun 2014 10:17:39 EDT Treating Depression After ACS: Seeking an Optimal Treatment Duration Patients who were treated for persistent depression after an acute coronary syndrome experienced improved outcomes during treatment, but worsened outcomes after treatment ended. Wed, 04 Jun 2014 10:29:40 EDT High-Dose Statins: Protecting the Heart, Damaging the Kidneys? Probably Not An analysis of 2 randomized trials of statin therapy for patients enrolled after an acute coronary syndrome finds that high-dose statins do not increase the risk of kidney injury. Fri, 09 May 2014 02:38:40 EDT Depression Identified as a Risk Factor for Poor Prognosis After ACS A scientific statement from the American Heart Association concludes that depression should be categorized as a risk factor for poor prognosis after acute coronary syndrome. Wed, 23 Apr 2014 09:14:23 EDT Triple Antithrombotic Therapy: Reducing Ischemic Events vs. Major Bleeding Risk When one of the newer oral anticoagulants is introduced into the treatment mix for acute coronary syndrome patients, reduction of ischemic events must be balanced against increased risk of major bleeding events. Mon, 24 Feb 2014 04:19:28 EST Another Pharmacist Success: Improved Adherence After ACS Admission A trial found that in the year after hospitalization for acute coronary syndrome, patients who received personalized attention from a pharmacist had higher levels of medication adherence. Fri, 27 Dec 2013 09:00:21 EST Beta-Blockers May Increase Cardiac Risk During Surgery Patients who took beta-blockers during non-cardiac surgery had increased risk of acute coronary syndrome, decompensated heart failure, and arrhythmia, according to the results of a study. Tue, 26 Nov 2013 09:44:00 EST